Reduced dietary intake of pro-inflammatory Toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy men.

Nutr Metab Cardiovasc Dis

Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester, LE3 9QP, UK. Electronic address:

Published: March 2016

Background And Aims: Because pro-inflammatory stimulants of Toll-like receptor-2 and TLR4 (pathogen-associated molecular patterns, PAMPs), are abundant in some processed foods, we explored the effects of diets enriched or depleted in these molecules on markers of cardiometabolic risk in man.

Methods And Results: Adherence to a low PAMP diet for 7 days reduced LDL-cholesterol (-0.69 mM, P = 0.024) and abdominal circumference (-1.6 cm, P = 0.001) in 11 habitual consumers of high PAMP foodstuffs, and these markers, together with leukocyte counts (+14%, P = 0.017) increased significantly after 4 days consuming predominantly high PAMP foods. Change in LDL-cholesterol and leukocyte counts correlated well with change in frequency of intake of high PAMP foodstuffs per individual (r = 0.540, P = 0.0095 and r = 0.6551, P = 0.0009, respectively). In an independent group of 13 healthy men, leukocyte counts and expression of the activation marker CD11b on granulocytes and monocytes were significantly reduced after a fresh onion meal (P < 0.05), but these effects were reversed by a high PAMP equivalent meal.

Conclusions: A low PAMP diet is associated with reduced levels of several cardiometabolic risk factors, while a high PAMP diet reverses these effects. These findings suggest a novel potential mechanistic explanation for the observed association between processed food consumption and risk of cardiometabolic diseases. The study is registered at clinicaltrials.org (reference NCT02430064).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.numecd.2015.12.001DOI Listing

Publication Analysis

Top Keywords

high pamp
20
cardiometabolic risk
12
pamp diet
12
leukocyte counts
12
markers cardiometabolic
8
healthy men
8
low pamp
8
pamp foodstuffs
8
pamp
7
high
5

Similar Publications

Article Synopsis
  • The text discusses the importance of forecasting future health issues in the USA for effective planning and public awareness regarding disease and injury burdens.
  • It describes the methodology for predicting life expectancy, cause-specific mortality, and disability-adjusted life-years (DALYs) from 2022 to 2050 using the Global Burden of Diseases framework.
  • The forecasting includes various scenarios to assess the potential impacts of health risks and improvements across the country, focusing on demographic trends and health-related risk factors.
View Article and Find Full Text PDF
Article Synopsis
  • Luciferase is a bioluminescent enzyme commonly used as a reporter to study gene expression in bioassays due to its high accuracy and wide dynamic range.
  • The study focuses on how plants respond to pathogen-associated molecular patterns (PAMPs), showing that treatment with bacterial PAMP flg22 and Phytophthora elicitin INF1 rapidly activates defense-related genes.
  • Researchers created transgenic plants with luciferase as a reporter to measure gene expression changes from PAMP treatment, finding increased luciferase activity, which indicates the effectiveness of this method in studying plant immune responses.
View Article and Find Full Text PDF

Background: Over the past several decades, the overweight and obesity epidemic in the USA has resulted in a significant health and economic burden. Understanding current trends and future trajectories at both national and state levels is crucial for assessing the success of existing interventions and informing future health policy changes. We estimated the prevalence of overweight and obesity from 1990 to 2021 with forecasts to 2050 for children and adolescents (aged 5-24 years) and adults (aged ≥25 years) at the national level.

View Article and Find Full Text PDF
Article Synopsis
  • Pulmonary arterial hypertension (PAH) is a serious vascular disease that leads to high pressure in the pulmonary arteries, resulting in rights heart failure and increased mortality.
  • This study provides a comprehensive analysis of PAH across 204 countries from 1990 to 2021, using global epidemiological data to quantify its impact as a distinct cause of death and disability.
  • In 2021, there were approximately 192,000 PAH cases worldwide, predominantly in females, with an observed improvement in the overall burden of the disease over time, showcasing a 38.2% reduction in years of life lost since 1990.
View Article and Find Full Text PDF

Background: Antibodies blocking programmed death (PD)-1 or its ligand (PD-L1) have revolutionized cancer care, but many patients do not experience durable benefits. Novel treatments to stimulate antitumor immunity are needed in the PD-(L)1 refractory setting. The stimulator of interferon genes (STING) protein, an innate sensor of cytoplasmic DNA, is a promising target with several agonists in development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!